Cargando…

Depsipeptide Companeramides from a Panamanian Marine Cyanobacterium Associated with the Coibamide Producer

[Image: see text] Two new cyclic depsipeptides, companeramides A (1) and B (2), have been isolated from the phylogenetically characterized cyanobacterial collection that yielded the previously reported cancer cell toxin coibamide A (collected from Coiba Island, Panama). The planar structures of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vining, Oliver B., Medina, Rebecca A., Mitchell, Edward A., Videau, Patrick, Li, Dong, Serrill, Jeffrey D., Kelly, Jane X., Gerwick, William H., Proteau, Philip J., Ishmael, Jane E., McPhail, Kerry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society and American Society of Pharmacognosy 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380200/
https://www.ncbi.nlm.nih.gov/pubmed/25562664
http://dx.doi.org/10.1021/np5007907
Descripción
Sumario:[Image: see text] Two new cyclic depsipeptides, companeramides A (1) and B (2), have been isolated from the phylogenetically characterized cyanobacterial collection that yielded the previously reported cancer cell toxin coibamide A (collected from Coiba Island, Panama). The planar structures of the companeramides, which contain 3-amino-2-methyl-7-octynoic acid (Amoya), hydroxy isovaleric acid (Hiva), and eight α-amino acid units, were established by NMR spectroscopy and mass spectrometry. The absolute configuration of each companeramide was assigned using a combination of Marfey’s methodology and chiral-phase HPLC analysis of complete and partial hydrolysis products compared to commercial and synthesized standards. Companeramides A (1) and B (2) showed high nanomolar in vitro antiplasmodial activity but were not overtly cytotoxic to four human cancer cell lines at the doses tested.